In the present study, we treated the aggressive Arctic48 mouse model of AD with PMX205 after substantial amyloid plaques were already present to determine the protective effects of C5aR1 inhibition in advanced amyloid pathology. Here, C5AR1 is linked to Alzheimer disease.